vs
Side-by-side financial comparison of PRECISION BIOSCIENCES INC (DTIL) and Ellomay Capital Ltd. (ELLO). Click either name above to swap in a different company.
PRECISION BIOSCIENCES INC is the larger business by last-quarter revenue ($34.2M vs $20.1M, roughly 1.7× Ellomay Capital Ltd.).
Precision BioSciences, Inc. is a publicly traded American clinical stage gene editing company headquartered in Durham, North Carolina. Founded in 2006, Precision is focused on developing both in vivo and ex vivo gene editing therapies using its proprietary "ARCUS" genome editing platform.
Ellomay Capital Ltd is a renewable energy enterprise focused on the development, ownership, and operation of clean power assets. Its portfolio includes solar photovoltaic projects, onshore wind farms, and pumped storage hydroelectric facilities, with core operations across Israel and key European markets, delivering low-carbon energy to both commercial and residential end consumers.
DTIL vs ELLO — Head-to-Head
Income Statement — Q4 FY2025 vs Q2 FY2025
| Metric | | |
|---|---|---|
| Revenue | $34.2M | $20.1M |
| Net Profit | $20.1M | — |
| Gross Margin | — | 12.1% |
| Operating Margin | 36.6% | -11.8% |
| Net Margin | 58.9% | — |
| Revenue YoY | 5261.1% | — |
| Net Profit YoY | 213.5% | — |
| EPS (diluted) | $2.62 | — |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $34.2M | — | ||
| Q3 25 | $13.0K | — | ||
| Q2 25 | $18.0K | $20.1M | ||
| Q1 25 | $29.0K | — | ||
| Q4 24 | $638.0K | — | ||
| Q3 24 | $576.0K | — | ||
| Q2 24 | $49.9M | $19.5M | ||
| Q1 24 | $17.6M | — |
| Q4 25 | $20.1M | — | ||
| Q3 25 | $-21.8M | — | ||
| Q2 25 | $-23.5M | — | ||
| Q1 25 | $-20.6M | — | ||
| Q4 24 | — | — | ||
| Q3 24 | $-16.4M | — | ||
| Q2 24 | $32.7M | — | ||
| Q1 24 | $8.6M | — |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | 12.1% | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | 8.7% | ||
| Q1 24 | — | — |
| Q4 25 | 36.6% | — | ||
| Q3 25 | -158976.9% | — | ||
| Q2 25 | -121538.9% | -11.8% | ||
| Q1 25 | -76248.3% | — | ||
| Q4 24 | — | — | ||
| Q3 24 | -3693.6% | — | ||
| Q2 24 | 48.4% | -9.3% | ||
| Q1 24 | -23.8% | — |
| Q4 25 | 58.9% | — | ||
| Q3 25 | -167476.9% | — | ||
| Q2 25 | -130666.7% | — | ||
| Q1 25 | -70913.8% | — | ||
| Q4 24 | — | — | ||
| Q3 24 | -2851.6% | — | ||
| Q2 24 | 65.6% | — | ||
| Q1 24 | 48.8% | — |
| Q4 25 | $2.62 | — | ||
| Q3 25 | $-1.84 | — | ||
| Q2 25 | $-2.13 | — | ||
| Q1 25 | $-2.21 | — | ||
| Q4 24 | — | — | ||
| Q3 24 | $-2.25 | — | ||
| Q2 24 | $4.67 | — | ||
| Q1 24 | $1.70 | — |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $115.6M | $54.5M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $92.2M | $171.5M |
| Total Assets | $154.4M | $855.5M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $115.6M | — | ||
| Q3 25 | $44.9M | — | ||
| Q2 25 | $62.2M | $54.5M | ||
| Q1 25 | $77.2M | — | ||
| Q4 24 | $86.3M | — | ||
| Q3 24 | $101.2M | — | ||
| Q2 24 | $123.6M | $59.9M | ||
| Q1 24 | $137.8M | — |
| Q4 25 | $92.2M | — | ||
| Q3 25 | $16.6M | — | ||
| Q2 25 | $34.1M | $171.5M | ||
| Q1 25 | $49.3M | — | ||
| Q4 24 | $56.4M | — | ||
| Q3 24 | $64.9M | — | ||
| Q2 24 | $74.7M | $136.3M | ||
| Q1 24 | $37.2M | — |
| Q4 25 | $154.4M | — | ||
| Q3 25 | $93.5M | — | ||
| Q2 25 | $108.9M | $855.5M | ||
| Q1 25 | $124.4M | — | ||
| Q4 24 | $136.4M | — | ||
| Q3 24 | $153.3M | — | ||
| Q2 24 | $165.8M | $678.9M | ||
| Q1 24 | $184.7M | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-11.3M | $5.1K |
| Free Cash FlowOCF − Capex | $-11.3M | — |
| FCF MarginFCF / Revenue | -32.9% | — |
| Capex IntensityCapex / Revenue | 0.1% | — |
| Cash ConversionOCF / Net Profit | -0.56× | — |
| TTM Free Cash FlowTrailing 4 quarters | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-11.3M | — | ||
| Q3 25 | $-15.3M | — | ||
| Q2 25 | $-20.3M | $5.1K | ||
| Q1 25 | $-19.1M | — | ||
| Q4 24 | $-58.4M | — | ||
| Q3 24 | $-5.9M | — | ||
| Q2 24 | $-14.9M | $468.0K | ||
| Q1 24 | $-19.0M | — |
| Q4 25 | $-11.3M | — | ||
| Q3 25 | — | — | ||
| Q2 25 | $-20.3M | — | ||
| Q1 25 | $-19.1M | — | ||
| Q4 24 | $-58.7M | — | ||
| Q3 24 | $-6.0M | — | ||
| Q2 24 | $-14.9M | — | ||
| Q1 24 | $-19.1M | — |
| Q4 25 | -32.9% | — | ||
| Q3 25 | — | — | ||
| Q2 25 | -112627.8% | — | ||
| Q1 25 | -65917.2% | — | ||
| Q4 24 | -9199.8% | — | ||
| Q3 24 | -1033.2% | — | ||
| Q2 24 | -29.9% | — | ||
| Q1 24 | -108.4% | — |
| Q4 25 | 0.1% | — | ||
| Q3 25 | 0.0% | — | ||
| Q2 25 | 11.1% | — | ||
| Q1 25 | 220.7% | — | ||
| Q4 24 | 39.2% | — | ||
| Q3 24 | 6.8% | — | ||
| Q2 24 | 0.1% | — | ||
| Q1 24 | 0.5% | — |
| Q4 25 | -0.56× | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | -0.45× | — | ||
| Q1 24 | -2.21× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
